US Senator Kirsten Gillibrand
Gillibrand Urges Drug Manufacturer To Update Medication Label To Protect Women Experiencing Miscarriage
U.S. Senator Kirsten Gillibrand joined 7 of her Senate colleagues in sending a letter to Danco Laboratories, a manufacturer of mifepristone, urging them to submit an application to the Food and Drug Administration (FDA) to add miscarriage management to the medication’s label.